Scientists tested two experimental antiviral drug. Their effectiveness was confirmed in the course of global clinical trials. According to The India Times, the drugs are able to quickly and effectively deal with the causative agent of hepatitis C even in the most severe and severe stages of the disease.
Scientists talk about a bunch of declarative and sofoluwe. Funds are classified as antiviral. It is noted that they receive help even those patients who are not saved triple dose of traditional medicines, aimed at combating infectious agent.
The drugs inhibit the replication process of the virus and cause rapid destruction of the structure of viral RNA. It should be noted that the bundle has not only excellent therapeutic properties, but does not cause the rapid development of resistance to therapy. Scientists have high hopes for its development and hope that soon it will be available for the treatment of patients.